The Products at the Center of MDL 3060
Documented product-use history is what turns a claimant into a signable, named-defendant case.
Hair Relaxer Lawsuit Leads for Law Firms - Since 2009
Most vendors sell you a cost per lead. Your controller cares about cost per signed, un-rejectable case. We deliver exclusive, SOL-screened, SB 37-compliant hair relaxer cancer claimants qualified to the MDL 3060 criteria your steering-committee buyers actually enforce - priced to the bellwether calendar, before the first verdict resets the market. If a lead doesn't match your criteria, we replace it at no cost.
The Number You Should Actually Buy On
Across the hair relaxer market, a large share of raw social inventory is rejected within 48 hours - almost always for incomplete exposure documentation or a diagnosis date that falls outside the filing state's statute of limitations. A cheap lead that never signs is the most expensive lead you can buy. We price and deliver on the back of the funnel, not the front.
A name and a number from a pooled budget, sold to whoever bids. You find out what you actually bought after your intake team has already spent the week on it.
Claimants qualified to the exact gates your PSC buyers enforce, documented to survive intake and a filing-state SOL check, and priced against the number that actually reaches your docket.
For reference, raw qualified hair relaxer leads have traded in roughly the $50-$120 per-record range on paid social, with broader agency CPL quoted around $800-$1,200 and per-lead legal pricing spanning $50-$500+ depending on exclusivity. Verified, documented inventory runs a premium over raw - and converts at a multiple of it. Tell us your qualification stack and we'll model the only number that matters: your cost per signed case.
Where MDL 3060 Actually Stands
The federal hair relaxer litigation - In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, MDL No. 3060, before Judge Mary M. Rowland in the Northern District of Illinois - crossed roughly 11,371 pending cases in mid-2026. With AFFF's filing window closed, it is one of the largest mass torts still actively taking new cases.
The science anchor is the 2022 NIH Sister Study: frequent use of chemical straighteners carried a 2.55× uterine cancer hazard ratio, with lifetime risk to age 70 rising from 1.64% to 4.05%. No bellwether verdict has priced this docket yet - which is exactly why the acquisition window is open now.
N.D. Illinois · Judge Mary M. Rowland · Special Settlement Master Ellen K. Reisman appointed. Parallel state dockets active in Pennsylvania, Illinois, Georgia, and New York. Status reflects publicly reported information as of mid-2026.
The Products at the Center of MDL 3060
Documented product-use history is what turns a claimant into a signable, named-defendant case.
What Makes a Case Signable
We build every hair relaxer case to the criteria your steering-committee buyers enforce, anchored to the Sister Study exposure profile. A record has to clear all six before it reaches your intake team.
Defendants in the litigation include L'Oréal / SoftSheen-Carson, Revlon, Strength of Nature, Godrej, Namaste, Dabur, and others. You set the gates; we deliver only what clears them, and replace anything that doesn't match at no cost.
Why the Window Is Open - and Narrowing
In mass tort, the procedural calendar is the most reliable predictor of acquisition cost. The first verdict has not landed - and every credible source expects cost per case to jump sharply once it does. Here is where the docket sits and what each step means for your buy.
The 2026 Rule Your Vendor Isn't Solving
As of January 1, 2026, California's SB 37 holds the law firm directly responsible for the compliance of the advertisement that generated its lead - even when the firm never wrote it. Every ad and intake funnel reaching a California consumer must name a responsible attorney and a bona fide office location, and must drop outcome guarantees and "fast settlement cash" language.
A single non-compliant landing page, replicated across a national campaign, is now a seven-figure exposure - and other states are already copying the model. We build California-eligible traffic on a separate, disclosure-compliant funnel so the leads you buy don't become a liability you inherit.
Litigation Update
The developments shaping case acquisition right now - and what each one means for a firm building docket. Status reflects publicly reported information as of mid-2026; ask us for the current posture before you launch.
| Development | Facts & Figures | Effect on Case Acquisition |
|---|---|---|
| Docket Scale | MDL 3060 crossed roughly 11,371 pending cases in mid-2026 (about 15,500 filed cumulatively), tripling in 30 months and ranking among the largest active mass torts. | A large, still-growing docket signals durable litigation and shared work product, making early claimant acquisition attractive for firms entering now. |
| Pre-Verdict Pricing | No bellwether verdict has landed. Raw leads have traded around $50-$120/record, with agency CPL near $800-$1,200. | Acquisition cost is widely expected to spike 40-60% after the first verdict. Building inventory now locks in pre-verdict economics. |
| Special Master Appointed | Ellen K. Reisman (J&J talc, 3M Combat Arms, DePuy) was appointed to coordinate settlement discussions across the MDL and parallel state proceedings. | A staging move toward eventual resolution. Firms with filed, qualified inventory are positioned ahead of any framework, not scrambling to build one. |
| Parallel State Dockets | Coordinated proceedings are active in Philadelphia, Illinois, Georgia (a favorable statute-of-repose ruling for plaintiffs), and New York, alongside the federal MDL. | State tracks widen the pool of qualifying claimants and can move faster than a 2027 federal trial - so leads must be sorted to the right venue. |
| SB 37 Vendor Liability | Effective Jan 1, 2026, California law makes firms liable for their vendors' ad compliance, with statutory damages of $5,000-$100,000 per violation. | Raises the stakes on where your leads come from. Compliant, attributable funnels are now a case-acquisition requirement, not a nicety. |
Why Choose Injury Case Claims
We've delivered more than 60,000 high-quality leads to satisfied law firms over 15+ years. On a documentation-heavy cancer tort where intake rejection is the real cost, our verification stack, non-incentivized intake, and compliant funnels are the difference between a docket and a refund fight.
Formats & Delivery
Law firms buy hair relaxer leads from us in three formats, each qualified against the same six gates and delivered exclusively to one firm - by CRM integration, email, or live handoff.
Fully executed hair relaxer retainers - signed cases delivered with the exposure history, dated diagnosis, and consent documentation already in the file. The closest thing to docket-in-a-box this tort offers.
Hair relaxer lawsuit leads for attorneys who run their own retainer process - screened by non-incentivized intake specialists, SOL-checked, never resold, and replaced free if one doesn't match your criteria.
Warm claimant transfers routed to your intake desk in real time, with Spanish-language capability - built for firms that convert best on the phone and want zero speed-to-lead lag.
Whether you're buying hair relaxer leads to open a new docket or topping up an existing MDL 3060 inventory, every campaign is built to your criteria: qualifying diagnoses, filing states, monthly volume, and delivery format. Our verification services layer ID checks and fraud screening onto every record, and firms scaling aggressively can pair campaigns with litigation funding to keep acquisition ahead of the bellwether calendar.
Hair relaxer is one vertical in our mass tort lead generation practice - the same screening infrastructure runs our talcum powder, Depo-Provera, and Ozempic campaigns, and our broader legal lead generation work across MVA and personal injury. See campaign pricing for current hair relaxer lead costs, or call (800) 889-1679 for a same-day quote.
Full Compliance
Operating since 2009, we've built processes that keep claimants treated fairly and their privacy respected - and that keep the firms who buy from us on the right side of TCPA, HIPAA, ABA, CCPA, and the new 2026 advertising rules like California's SB 37.
Decades of Experience
Hair relaxer cases live or die on documentation and timing - the right exposure history, a diagnosis inside the SOL, and a compliant intake are what separate a signed file from a refund request. If you want an agency that delivers claimants you can build into real, filed cases, work with the one that has delivered more than 60,000 leads across practice areas since 2009.
Get Started
If your firm is building a hair relaxer docket - or a broader mass tort, MVA, or Personal Injury pipeline - give us the criteria and target volume, and we'll map a delivery plan against the current bellwether calendar.
We promise the best quality with the industry's best return policy. No other company offers investment protection like we do.
Instant updates so you never miss an opportunity.
Six-gate screened and SOL-checked before delivery.
Pre-verdict cost per signed case, modeled to your criteria.
SB 37, TCPA and HIPAA handled - and your data protected.
EST. 2009 ★★★★★
By submitting, you consent to be contacted by InjuryCaseClaims.com regarding your inquiry. This does not constitute a binding agreement. All information is handled securely and confidentially.
FAQ
Everything your firm needs to know before launching your first hair relaxer campaign with Injury Case Claims.